Yi He

1882 Zhonghuan South Road
Jiaxing, 314000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

A retrospective observational analysis of the global burden of smoking-attributable prostate, bladder, and kidney cancers among adults aged 40 years and older: Based on the global burden of disease study 2021 with projections to 2045.

A retrospective observational analysis of the global burden of smoking-attributable prostate, bladder, and kidney cancers among adults aged 40 years and older: Based on the global burden of disease study 2021 with projections to 2045.

Journal: Science progress

Published: July 09, 2026

7,8-Dihydroxyflavone alleviates chronic prostatitis/chronic pelvic pain syndrome via modulation of the TrkB/AKT/ERK/SIRT3 signaling axis.

7,8-Dihydroxyflavone alleviates chronic prostatitis/chronic pelvic pain syndrome via modulation of the TrkB/AKT/ERK/SIRT3 signaling axis.

Journal: International immunopharmacology

Published: June 12, 2026

Urine IRF4/PENK/PXDN Methylation Signatures Enable Machine Learning-Driven Bladder Cancer Detection and Microenvironment Dissection.

Urine IRF4/PENK/PXDN Methylation Signatures Enable Machine Learning-Driven Bladder Cancer Detection and Microenvironment Dissection.

Journal: Technology in cancer research & treatment

Published: June 11, 2026

Non-α-biased IL-2 enhances both intratumoral and subcutaneous CpG/α-OX40 therapy, unleashing systemic antitumor immunity in mice.

Non-α-biased IL-2 enhances both intratumoral and subcutaneous CpG/α-OX40 therapy, unleashing systemic antitumor immunity in mice.

Journal: Journal for immunotherapy of cancer

Published: November 25, 2025

Targeting urological cancers with CAR-T cell therapy: current landscape and future directions.

Targeting urological cancers with CAR-T cell therapy: current landscape and future directions.

Journal: Journal of translational medicine

Published: November 07, 2025

Urinary DNA Methylation Profiling Improves Discrimination of Prostate Cancer Across PSA-Defined Risk Strata.

Urinary DNA Methylation Profiling Improves Discrimination of Prostate Cancer Across PSA-Defined Risk Strata.

Journal: Biochemical genetics

Published: August 01, 2025

7,8-dihydroxyflavone attenuates NIH IIIA subtype chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) via TrkB/AKT/SIRT3 signaling activation.

7,8-dihydroxyflavone attenuates NIH IIIA subtype chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) via TrkB/AKT/SIRT3 signaling activation.

Journal: Translational andrology and urology

Published: July 23, 2025

First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial.

First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial.

Journal: The Lancet. Oncology

Published: March 18, 2025

Retracted: IC-2 Suppresses Proliferation and Induces Apoptosis of Bladder Cancer Cells via the Wnt/β-Catenin Pathway.

Retracted: IC-2 Suppresses Proliferation and Induces Apoptosis of Bladder Cancer Cells via the Wnt/β-Catenin Pathway.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: February 19, 2025

Reversing enhancer RNA-mediated IKBKE gene repression enables synthetic anticancer immunity in prostate cancer models.

Reversing enhancer RNA-mediated IKBKE gene repression enables synthetic anticancer immunity in prostate cancer models.

Journal: The Journal of clinical investigation

Published: January 03, 2025

Exploration of a prognostic signature for mitochondria-related genes and the therapeutic prospects of vorinostat in clear cell renal cell carcinoma.

Exploration of a prognostic signature for mitochondria-related genes and the therapeutic prospects of vorinostat in clear cell renal cell carcinoma.

Journal: Translational andrology and urology

Published: October 10, 2024

Biological clock regulation by the PER gene family: a new perspective on tumor development.

Biological clock regulation by the PER gene family: a new perspective on tumor development.

Journal: Frontiers in cell and developmental biology

Published: November 03, 2023

Showing 1-12 of 33

Last Updated: 09/26/2026